2 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 2 |
Follow Recurrent Small Cell Lung Cancer: new trials by email Literature Review of Recurrent Small Cell Lung Cancer trials Research Report on Recurrent Small Cell Lung Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Topotecan Hydrochloride or Cyclodextrin-Based Polymer-Camptothecin CRLX101 in Treating Patients With Recurrent Small Cell Lung Cancer topotecan hydrochloride, cyclodextrin-based polymer-camptothecin CRLX101 - Extensive Stage Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer | Phase 2 | Terminated | University of Chicago | 29 | 2013-01-16 | 2020-06-26 |
| Rebeccamycin Analog as Second-Line Therapy in Treating Patients With Limited-Stage or Extensive-Stage Small Cell Lung Cancer That Relapsed After Previous First-Line Chemotherapy becatecarin - Extensive Stage Small Cell Lung Cancer, Limited Stage Small Cell Lung Cancer | Phase 2 | Terminated | National Cancer Institute (NCI) | 21 | 2004-04-01 | 2014-05-23 |
Bronchial Neoplasms (2) · Carcinoma, Bronchogenic (2) · Lung Diseases (2) · Lung Neoplasms (2) · Neoplasms (2) · Neoplasms by Site (2) · Respiratory Tract Diseases (2) · Respiratory Tract Neoplasms (2) · Thoracic Neoplasms (2)
IT-101 (1) · Topotecan (1) · becatecarin (1) · trioctyl phosphine oxide (1)
National Cancer Institute (NCI) (1) · University of Chicago (1)
United States (2)
Afshin Dowlati (1) · Ravi Salgia (1)
P30CA043703 (1), U01CA062502 (1)